From July 3 to July 6, 2016, Helsinki hosted the ESHRE 32nd Annual Meeting, bringing together over 9,000 global experts, clinical embryologists, reproductive endocrinologists, and medical technology developers.
The scientific program highlighted major breakthroughs in next-generation sequencing (NGS) for preimplantation genetic screening, automated incubator microclimate control, and optimized vitrification protocols.
The LLC ART MEDICAL LTD delegation focused its presence in Helsinki on strategic B2B management, commercial performance evaluations, and identifying prospective technologies for Ukrainian fertility units.
Key Working Priorities:
-
Executive B2B Meetings with Manufacturing Partners: Conducted targeted sessions with executive leaders of the international brands we represent in Ukraine. Delivered comprehensive sales statistics, evaluated market adoption trends for microinstruments, and aligned import targets for the second half of the year.
-
Market Intelligence & Industry Innovation Review: Explored technological advances in NGS workflows, culture media formulations, and cryo-storage hardware to assess their potential implementation across domestic clinics.
-
Sourcing New Manufacturing Partners: Initiated strategic communications and held preliminary meetings with emerging international developers of consumables and labware to further diversify our supply portfolio.
Participating in ESHRE 2016 in Helsinki enabled LLC ART MEDICAL LTD to review mid-year performance metrics with key manufacturers, structure supply channels for the upcoming period, and establish promising new international partnerships.
We express our appreciation to all global partners for their continued trust and constructive engagement!